💊
Orladeyo
berotralstat
Angioedeme, ereditare
✅ Autorizat
✅
Nu există alerte active
Acest medicament nu are penurii în curs, scrisori de siguranță sau retrageri de pe piață.
La ce se utilizează
Orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE) in adult and adolescent patients aged 12 years and older weighing at least 40 kg. Orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE) in: children aged 2 to less than 12 years weighing at least 15 kg adolescents aged 12 and older weighing less than 40 kg
⚠️ Siguranță a pacientului
No
Pagina oficială EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/orladeyo